European pharma leaders warn industry is losing ground as R&D share falls to 31%
AI Summary- Nine European pharmaceutical board chairs urged governments to change policies supporting the industry.
- Europe's pharmaceutical R&D share fell from 43% in 1990 to 31% today.
- China's five-year plan targets 25% of first-in-class drugs, while EU leaders seek faster trials.